Pasar al contenido principal

Andrea Guala

Andrea Guala is a post-doc researcher working in Cardiovascular Imaging analysis. After a PhD at the Politecnico of Turin (Italy) about modelling of the heart and large arteries, he moved to the Vall D’Hebron Institute of Research thanks to a Marie-Curie Post-Doctoral grant, starting on May 2016. From 2019 his work is supported by a Juan de la Cierva post-doctoral grant. His main research line relates to the developed of image analysis codes to assess biomarkers from multi-modality cardiovascular images and their evaluation as descriptors of aortic and heart diseases and as predictors of patients’ clinical evolution. As per September 2021, Andrea co-authored 39 peer-review scientific publications. Among them, he was first authors in papers published in the most important journals of cardiology, such the European Heart Journal, Circulation and JACC cardiovascular imaging. During his stay in Barcelona, Andrea’s work has been awarded by the Marie Sklodowska-Curie Acciones seal of excellence (2017), several travel grants to attend international conferences and a number of conference awards. He collaborates in a several projects funded by regional, national and European bodies and collaborates with many researchers from all over the world

Instituciones de las que forman parte

Investigador/a principal
Enfermedades Cardiovasculares
Vall Hebron Institut de Recerca

Andrea Guala

Instituciones de las que forman parte

Investigador/a principal
Enfermedades Cardiovasculares
Vall Hebron Institut de Recerca

Andrea Guala is a post-doc researcher working in Cardiovascular Imaging analysis. After a PhD at the Politecnico of Turin (Italy) about modelling of the heart and large arteries, he moved to the Vall D’Hebron Institute of Research thanks to a Marie-Curie Post-Doctoral grant, starting on May 2016. From 2019 his work is supported by a Juan de la Cierva post-doctoral grant. His main research line relates to the developed of image analysis codes to assess biomarkers from multi-modality cardiovascular images and their evaluation as descriptors of aortic and heart diseases and as predictors of patients’ clinical evolution. As per September 2021, Andrea co-authored 39 peer-review scientific publications. Among them, he was first authors in papers published in the most important journals of cardiology, such the European Heart Journal, Circulation and JACC cardiovascular imaging. During his stay in Barcelona, Andrea’s work has been awarded by the Marie Sklodowska-Curie Acciones seal of excellence (2017), several travel grants to attend international conferences and a number of conference awards. He collaborates in a several projects funded by regional, national and European bodies and collaborates with many researchers from all over the world

.

Proyectos

DataTools4Heart: A European Health Data Toolbox for Enhancing Cardiology Data Interoperability, Reusability and Privacy

IP: Jose Fernando Rodríguez Palomares
Colaboradores: Alicia Fresno González, Alessandro Giustiniani, Ignacio Ferreira González, Gisela Teixido Tura, Juan Garrido Oliver, Aroa Ruiz Muñoz, Lydia Dux-Santoy Hurtado, Andrea Guala, Andrea Guala, Andrea Guala
Entidad financiadora: EUROPEAN COMMISSION
Financiación: 322500
Referencia: DATATOOLS4HEART_HE-HLTH-TOOL21
Duración: 01/10/2022 - 30/09/2026

CardioP3T: Nuevos biomarcadores de diagnóstico y pronóstico en patología cardíaca a partir de técnicas de imagen híbrida PET-RM

IP: Jose Fernando Rodríguez Palomares
Colaboradores: Lydia Dux-Santoy Hurtado, Andrea Guala
Entidad financiadora: Ministerio de Ciencia e Innovación-MICINN
Financiación: 138065.8
Referencia: RTC2019-007280-1
Duración: 01/01/2020 - 31/12/2023

Ministerio de Ciencia

ANEURISMAS DE AORTA ASCENDENTE. PROGRESION DE LA DILATACION: ETIOPATOGENIA Y NUEVOS BIOMARCADORES DE IMAGEN PARA PREDECIR SU EVOLUCION

IP: ANEURISMAS DE AORTA ASCENDENTE. PROGRESION DE LA DILATACION: ETIOPATOGENIA Y NUEVOS BIOMARCADORES DE IMAGEN PARA PREDECIR SU EVO
Colaboradores: Jose Fernando Rodríguez Palomares, Rafael Rodríguez Lecoq, Gisela Teixido Tura, Aroa Ruiz Muñoz, Hug Cuellar Calabria, Lydia Dux-Santoy Hurtado, Andrea Guala
Entidad financiadora: Instituto de Salud Carlos III
Financiación: 134310
Referencia: PI17/00381
Duración: 01/01/2018 - 30/06/2022

'Innovative techniques for analysing the interaction between aortic valve dysfunction and aortic dilation

IP: 'Innovative techniques for analysing the interaction between aortic valve dysfunction and aortic dilation
Colaboradores: Andrea Guala, Miriam Izquierdo Sans
Entidad financiadora: EUROPEAN COMMISSION
Financiación: 43560
Referencia: INCOMED - FELLOW 5
Duración: 01/05/2016 - 28/02/2018

Noticias relacionadas

El proyecto europeo, en el que participa Vall d’Hebron, favorecerá el diagnóstico personalizado y estrategias terapéuticas innovadoras en pacientes con la enfermedad.

Coincidiendo con el Día Internacional de las Mujeres, organizamos una acción comunicativa para luchar contra el androcentrismo en cinco cuestiones médicas: ictus, enfermedades cardiovasculares, migraña, cáncer y respuesta a los medicamentos.

En los pacientes con infarto agudo de miocardio, la detección de cierto grado de necrosis en los músculos papilares del ventrículo izquierdo mediante RM cardiaca se asocia a una mayor probabilidad de muerte, arritmias e insuficiencia cardíaca.

Profesionales relacionados

Josep Maria de Bergua Domingo

Josep Maria de Bergua Domingo

Investigador predoctoral
Bioingeniería, Terapia Celular y Cirugía en Malformaciones Congénitas
Leer más
Olga Mendez Fernández

Olga Mendez Fernández

Investigador/a principal
Investigación Biomédica en Urología
Leer más
Anna Rey Pérez

Anna Rey Pérez

Investigador predoctoral
Unidad de Investigación en Neurotraumatología y Neurocirugía (UNINN)
Leer más
Olga Maisterra Santos

Olga Maisterra Santos

Investigador/a principal
Enfermedades Neurovasculares
Leer más

Suscríbete a nuestros boletines y forma parte de la vida del Campus

Vall d'Hebron Barcelona Hospital Campus es un parque de referencia mundial donde la asistencia, la investigación, la docencia y la innovación se dan la mano.